HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer - Wikidata - wikimedia - TriplyDB

HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer

HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer

http://www.wikidata.org/entity/Q33686182

about

HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer

http://www.wikidata.org/entity/Q33686182

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

HER2 Pro1170Ala polymorphism i ...... in HER2-negative breast cancer

@ast

HER2 Pro1170Ala polymorphism i ...... in HER2-negative breast cancer

@en

type

label

HER2 Pro1170Ala polymorphism i ...... in HER2-negative breast cancer

@ast

HER2 Pro1170Ala polymorphism i ...... in HER2-negative breast cancer

@en

prefLabel

HER2 Pro1170Ala polymorphism i ...... in HER2-negative breast cancer

@ast

HER2 Pro1170Ala polymorphism i ...... in HER2-negative breast cancer

@en

P1433

Q33686182-DB33682F-4E6C-4BC5-BD68-6DA5B869E723

P1476

Q33686182-041AAAA4-37F2-41D1-B50C-B322FEEF577E

P2093

Q33686182-206C87B8-C9EA-4143-A07B-EFE598ED2112

Q33686182-2BE7BC56-25AF-4CD4-8AE1-7DF80B11A68B

Q33686182-4657A149-F34B-492A-9DDC-10ADAA3165A9

Q33686182-4F197E38-0D2E-443D-8910-262423117408

Q33686182-6EA13A40-7D97-44D2-AA36-9535472E7DAE

Q33686182-74187846-F23C-423D-BCB2-A40795FE6A11

Q33686182-8C7E8D1A-9752-4BD6-92C4-45E2F5DE0740

Q33686182-9D861945-19B3-464F-AD20-AFD1ADB952F4

Q33686182-A7AC8E4B-7BCC-49F4-9A97-EAF2AA81C43D

P2860

Q33686182-08AD4593-D800-4046-858E-4D07FA489DBF

Q33686182-155F7D39-FD7F-4096-B02B-D33C4EF04105

Q33686182-21AD77FB-A0C6-4CAA-882C-DDE887B02041

Q33686182-31B77FF5-30C3-4B84-A0A4-09F55051E74A

Q33686182-50B89328-844F-441E-9D02-CAE7C8480D4C

Q33686182-56FCCBAA-7FA5-4A7B-B9C0-521A96C31218

Q33686182-59A33E47-D934-4D32-9970-9228569B1CC9

Q33686182-64BDE55C-21C4-4AAA-BBF0-2BB464076E9C

Q33686182-65029F35-3A6B-4698-AFE1-75A02B086337

Q33686182-6A145D7E-4324-49E8-8771-864899DB6DD9

P304

Q33686182-D881D3A0-233D-465B-AE15-40EB0FBDB49D

P31

Q33686182-F6D7E88C-1C83-4A9A-9B36-5BF605B13910

P356

Q33686182-6051313E-1E58-4025-AB73-7070ACADAC87

P433

Q33686182-FA8F9C53-14E5-45AA-93A8-709BA92A524E

P478

Q33686182-D3D67C3B-96AE-42EE-BDC0-5F782204ED20

P577

Q33686182-F4FC4B08-B527-4D37-AC65-933F23A6CE06

P698

Q33686182-BD505945-BBDF-4451-90EF-6826A5788E3F

P932

Q33686182-8B48867A-A4F1-47C7-85F3-052EF24A21B5

P356

P1433

Oncology Letters

P1476

HER2 Pro1170Ala polymorphism i ...... in HER2-negative breast cancer

@en

P2093

Benyao Lin

http://www.w3.org/2001/XMLSchema#string

Jinfeng Li

http://www.w3.org/2001/XMLSchema#string

Pilei Si

http://www.w3.org/2001/XMLSchema#string

Tao Ouyang

http://www.w3.org/2001/XMLSchema#string

Tianfeng Wang

http://www.w3.org/2001/XMLSchema#string

Tie Fan

http://www.w3.org/2001/XMLSchema#string

Ye Xu

http://www.w3.org/2001/XMLSchema#string

Yuntao Xie

http://www.w3.org/2001/XMLSchema#string

Zhaoqing Fan

http://www.w3.org/2001/XMLSchema#string

P2860

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

A putative molecular-activation switch in the transmembrane domain of erbB2.

The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population

Evidence that autophosphorylation of solubilized receptors for epidermal growth factor is mediated by intermolecular cross-phosphorylation

Epidermal growth factor receptor: mechanisms of activation and signalling.

P304

3793-3798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.5866

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28529593

http://www.w3.org/2001/XMLSchema#string

P932

5431611

http://www.w3.org/2001/XMLSchema#string